Coenzyme-A Inc.

OTC: PPII · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Lynnwood, WA · SnohomishReports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 35

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ market scale, listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-08-03

Market cap

$111

as of 2026-08-03

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Coenzyme-A Inc.’s financial profile?

Coenzyme-A Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Ormand Industries Inc——Hear AtLast Holdings, Inc.——Virpax Pharmaceuticals, Inc.——Enchanted World Inc.——Acusphere, Inc.——BC Craft Supply Co. Ltd.——

Neighbors

Snohomish →

Fortive Corporation$4.2B78B+Coastal Financial Corporation——Funko, Inc.$908.2M41D FS Bancorp, Inc.$4.6M54D Zumiez Inc.$929.1M67B Mountain Pacific Bancorp Inc$61.3M62C

Key facts

CEONickoloaus D. Skouras

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersLynnwood, WA

ExchangeOTC: PPII

Employees—

IPO date2009-09-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.